Cargando…
Mesenchymal stem cell-derived exosomes regulate microglia phenotypes: a promising treatment for acute central nervous system injury
There is growing evidence that long-term central nervous system (CNS) inflammation exacerbates secondary deterioration of brain structures and functions and is one of the major determinants of disease outcome and progression. In acute CNS injury, brain microglia are among the first cells to respond...
Autores principales: | Liu, Yu-Yan, Li, Yun, Wang, Lu, Zhao, Yan, Yuan, Rui, Yang, Meng-Meng, Chen, Ying, Zhang, Hao, Zhou, Fei-Hu, Qian, Zhi-Rong, Kang, Hong-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154505/ https://www.ncbi.nlm.nih.gov/pubmed/36751776 http://dx.doi.org/10.4103/1673-5374.363819 |
Ejemplares similares
-
The promise of exosome applications in treating central nervous system diseases
por: Mattingly, Jared, et al.
Publicado: (2021) -
Promising Therapeutic Functions of Bone Marrow Mesenchymal Stem Cells Derived-Exosome in Asthma
por: Yuan, Jia-Ying, et al.
Publicado: (2022) -
Galectin-3 in Microglia-Mediated Neuroinflammation: Implications for Central Nervous System Diseases
por: Ge, Meng-Meng, et al.
Publicado: (2022) -
Phagocytosis of Microglia in the Central Nervous System Diseases
por: Fu, Ruying, et al.
Publicado: (2014) -
Exosomes Secreted by Microglia During Virus Infection in the Central Nervous System Activate an Inflammatory Response in Bystander Cells
por: Luong, Nhungoc, et al.
Publicado: (2021)